Inoveli coronaviruses zezohlobo B. I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla. Ngokuqhelekileyo abantu basengozini. Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo; abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo. Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7. Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo. Ukuxinana kweempumlo, impumlo evuzayo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.
Le khithi isetyenziselwa ukufumanisa umgangatho we-in vitro wenoveli coronavirus 2019-nCov kwisampulu zokuphefumla ezibandakanya i-oropharyngeal swab, isikhohlela, i-bronchoalveolar lavage fluid kunye ne-nasopharyngeal swab. Iiseti zePrimer kunye ne-FAM ebhalwe probe ziyilelwe ukuchongwa kofuzo oluthile lwe-ORLab ye-2019-nCov. I-VIC ebhalwe i-probe ye-N gene ka-2019-nCov. I-gene ye-RNase ye-P yomntu ekhutshwe ngaxeshanye kunye nesampuli yovavanyo inika ulawulo lwangaphakathi lokuqinisekisa inkqubo ye-nucleic extraction kunye nokuthembeka kwe-reagent. Uphando olujolise kuhlobo lwe-RNase P yomntu lubhalwe nge-CY5.
Amacandelo | Iimvavanyo ezingama-50/ikhithi |
RT-PCR Reaction Mix Reagent | 240μL × 1 ityhubhu |
I-Enzyme Mix Reagent | 72μL × 1 ityhubhu |
I-2019-nCoV primer probe | 48μL × 1 ityhubhu |
Ulawulo oluhle | 200μL × 1 ityhubhu |
Ulawulo olubi | 200μL × 1 ityhubhu |
Uvakalelo: 200 iikopi/mL.
Ukucaciswa: Akukho mpendulo enqamlezileyo kunye ne-SARS-CoV, i-MERS-CoV, i-CoV-HKU1, i-CoV-OC43, i-CoV-229E, i-CoV-NL63 kunye ne-HIN1, i-H3N2, i-H5N1, i-H7N9, i-Influenza B, i-Parainfluenza Virus (123), i-Rhinovirus (A) ,B,C), Adenovirus (1,2,3,4,5,7,55), i-pneumovirus yabantu, i-metapneumovirus yabantu, i-EBv, intsholongwane yemasisi, intsholongwane ye-cytomegalic, intsholongwane yeRota, i-Norovirus, i-virus ye-Mumps, i-Varicella Zoster Virus, i-Mycoplasma pneumonia, i-Chlamydia pneumonia, Legionella, Bordetella pertussis, Haemophilus influenza, Staplhylococcus Aureus, Streptococcus Pneumonia, Streptococcus pyogenes, Klebsiella pneumonia, Tuberculous bacillus, Aspergillus fumigatus, Candida albicans, Candida glabrata, Cryptococcus neoformans.
Ukuchaneka: I-CV ≤5%.
Inkqubo yePCR yexesha langempela: Aehealth Diagenex AL, ABI 7500, ViiATM 7, Quant Studio 7 flex.Roche Lightcycler 480, Agilent Mx3000P/3005P, Rotor-Gene TM6000/0. I-Bio-Rad CEX96 Touch TM SLAN-96S.SLAN-96P
Umzi-mveliso wethu uneworkshop ecocekileyo ye-10,000 square metres, izixhobo ezingundoqo zokuvelisa zithunyelwa zivela eJamani, kwaye amaziko ama-5 e-R&D asekiwe kulo lonke ilizwe.
Iziko lethu le-R&D lithatha i-40% yabo bonke abasebenzi benkampani, i-70% yabo bonke abasebenzi bane-bachelor degree okanye ngaphezulu, kwaye i-30% ine-master degree okanye ngaphezulu.
Ngophando oluzimeleyo kunye nophuhliso, itekhnoloji ebalulekileyo efana neteknoloji yobunjineli bemfuza, iteknoloji yokulungiselela i-antibody eyodwa / polyclonal, kunye ne-molecule encinci ye-teknoloji ye-synthesis synthesis, enokusetyenziswa ukuvelisa ngokuzimeleyo ezinye zezinto ezifunekayo ze-bioactive, imidiya ye-chromatographic, ulawulo, iicalibrator kunye nezinye izinto eziqhelekileyo ezisetyenziswa ekrwada.
Iinkqubo zokulawula umgangatho ongqongqo wenkampani kunye nenkqubo yolawulo lomgangatho, umgangatho wenkqubo yokuvelisa, ukuhlolwa kwemveliso egqityiweyo, ukubeka iliso kunye nokuhlolwa, ulawulo olungqongqo lweenkqubo eziphambili.